TipRanks on MSN

LAVA Therapeutics Amends Share Purchase Agreement

LAVA Therapeutics ( ($LVTX) ) has provided an announcement. On October 17, 2025, LAVA Therapeutics N.V. and XOMA Royalty Corporation announced an ...

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

Amendment includes finalized cash amount and updated CVR terms for tender offer- LAVA announces new date for extraordinary general meeting of ...
Nasdaq

ZyVersa Therapeutics Enters Share Purchase Agreement with Williamsburg Venture Holdings to Advance Clinical Development of VAR 200

ZyVersa Therapeutics enters a $10 million share purchase agreement with Williamsburg Venture Holdings to advance kidney disease treatment development. ZyVersa Therapeutics, Inc. has announced a share ...
Morningstar

ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million in Partnership with Williamsburg Venture Holdings to Fund Clinical Development of Cholesterol ...

WESTON, Fla., June 25, 2025 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA; “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment ...
Morningstar

NameSilo Technologies Corp. Enters Definitive Share Purchase Agreement to Acquire 100% of SewerVUE Technology Corp.

VANCOUVER, BC, Sept. 12, 2025 /PRNewswire/ - NameSilo Technologies Corp. (CSE: URL) (PINKSHEETS: URLOF) (the "Company") is pleased to announce that it has entered into a definitive share purchase ...
Benzinga.com

Tharimmune Shares Are Trading Lower Tuesday: What's Going On?

Tharimmune, Inc. (NASDAQ:THAR) shares are trading lower Tuesday after the company announced it has entered into a $5.3 million securities purchase agreement. What To Know: Tharimmune said it entered ...